Search for: "Pharmacia "
Results 1 - 20
of 173
Sort by Relevance
|
Sort by Date
23 Jan 2024, 5:44 am
Pharmacia appeal the ruling. [read post]
5 Jul 2023, 7:33 am
”); Pharmacia Corp. v. [read post]
10 Aug 2022, 6:12 am
On August 4, 2022, the New Jersey Department of Environmental Protection (NJDEP) issued a press release announcing a lawsuit of sweeping, breathtaking scope against Monsanto, Solutia, and Pharmacia ─ all linked to the original Monsanto (“Old Monsanto”), which reorganized its businesses into three separate corporations in the late 1990s ─ seeking natural resource damages (NRDs) for polychlorinated biphenyl (PCB) contamination across the entire state of New Jersey. [read post]
10 Aug 2022, 6:12 am
On August 4, 2022, the New Jersey Department of Environmental Protection (NJDEP) issued a press release announcing a lawsuit of sweeping, breathtaking scope against Monsanto, Solutia, and Pharmacia ─ all linked to the original Monsanto (“Old Monsanto”), which reorganized its businesses into three separate corporations in the late 1990s ─ seeking natural resource damages (NRDs) for polychlorinated biphenyl (PCB) contamination across the entire state of New Jersey. [read post]
10 Aug 2022, 6:12 am
On August 4, 2022, the New Jersey Department of Environmental Protection (NJDEP) issued a press release announcing a lawsuit of sweeping, breathtaking scope against Monsanto, Solutia, and Pharmacia ─ all linked to the original Monsanto (“Old Monsanto”), which reorganized its businesses into three separate corporations in the late 1990s ─ seeking natural resource damages (NRDs) for polychlorinated biphenyl (PCB) contamination across the entire state of New Jersey. [read post]
1 Dec 2021, 1:29 pm
Pharmacia Corp. [read post]
12 Jul 2021, 12:29 am
Sugen LLC and Pharmacia & Upjohn Company In February 2019, the Moscow City Commercial Court granted a second compulsory license to Nativa for use of a drug named Sunitinib was protected by an Eurasian patent co-owned by Sugen LLC and Pharmacia & Upjohn Company, both of which were owned by Pfizer. [read post]
8 Sep 2020, 2:59 pm
As the Court in the insurance coverage litigation later summarized, the Garber Action alleged that Pfizer, as successor in interest to Pharmacia, had misled investors about the adverse gastrointestinal effects of Celebrex, an anti-inflammatory drug. [read post]
9 Jul 2020, 6:16 am
While the CJEU had initially endorsed a restrictive approach in Pharmacia Italia (C-31/03), MIT (C-431/04) and Yissum (C-202/05), it surprisingly made a complete U-turn in the Neurim judgment (C-130/11) rendered in 2012. [read post]
9 Jul 2020, 6:16 am
While the CJEU had initially endorsed a restrictive approach in Pharmacia Italia (C-31/03), MIT (C-431/04) and Yissum (C-202/05), it surprisingly made a complete U-turn in the Neurim judgment (C-130/11) rendered in 2012. [read post]
23 Jan 2020, 12:55 pm
The Neurim decision is highly controversial, as it is in conflict with the literal wording of the provisions of the SPC Regulation, as well as the previous standing case law, as evidenced by Pharmacia (C-31/03), Yissum (C-202/05) and MIT (C-431/04). [read post]
20 Dec 2019, 9:08 am
Humana will also acquire Enclara Pharmacia, GuidantRx, and Avanti Health Care Services from Consonance as part of the transaction, reports HealthLeaders. [read post]
20 Dec 2019, 9:08 am
Humana will also acquire Enclara Pharmacia, GuidantRx, and Avanti Health Care Services from Consonance as part of the transaction, reports HealthLeaders. [read post]
7 Aug 2019, 1:42 am
The IPCom guidance are provided for readers' convenience at the end of this post.The IPCom factors have since been applied in Actavis v Pharmacia [2014] EWHC 2265 (stay was ordered), and Eli Lilly v Janssen Sciences [2016] EWHC 313 (stay was not ordered) (IPKat post here).David Stone (sitting as a Deputy High Court Judge), applied the IPCom guidance to the fact of the case in Coloplast v Salts. [read post]
28 Jul 2019, 10:23 am
Pfizer acquired Pharmacia in April 2003. [read post]
21 Mar 2019, 10:16 am
Abraxis said they were, as there was an important therapeutic differences between the two and thus subject to two different MAs, the latter being the "first MA" (thus complying with Article 3(d)).Mr Justice Arnold considered there was inconsistency in the CJEU judgments as between Neurim and Pharmacia or Yissum. [read post]
23 Dec 2018, 4:01 am
The AG refers to CJEU case-law in Yissum and Pharmacia Italia, providing that the definition of the term “product” is independent of the therapeutic use concerned, meaning that an active ingredient or a “combination of active ingredients” remains the same product irrespective of the different therapeutic uses this might have. [read post]
3 May 2018, 11:02 am
Pharmacia Biotech, Inc., 225 F.3d 1315 (Fed. [read post]
5 Sep 2017, 2:50 pm
Pharmacia & Upjohn Absence Payment Plan, (2006), the Sixth Circuit re-iterated that while “some weight is to be given” to an SSA determination of total disability, “it is not binding. [read post]
25 Jan 2017, 11:25 pm
He notes that the Neurim decision seems to be inconsistent with the CJEU’s decisions in MIT, GSK, Pharmacia and Yissum. [read post]
